Eugenio Battaglia

Eugenio Battaglia

Aug 30, 2014

Group 6 Copy 86
0
    Please wait...

    About This Project

    BioPeers – Peers Center for Biotech and Society
    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Thermal and Fluid Dynamical Effects on the Efficiency of Hyperpolarized Xenon Production

    The American Lung Association estimates that 32 million Americans are affected by lung diseases, many of which...

    Can we noninvasively measure blood sugar for diabetes?

    Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

    You have mail: Stem Cell messages for fighting liver diseases

    The use of stem cells is currently limited by issues including the risk of tumor formation or undesired immune...

    Backer Badge Funded